<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001848717</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001479290</issuerCik>
            <issuerName>REVANCE THERAPEUTICS, INC.</issuerName>
            <secFileNumber>001-36297</secFileNumber>
            <issuerAddress>
                <ns2:street1>1222 Demonbreun Street, Suite 2000</ns2:street1>
                <ns2:city>Nashville</ns2:city>
                <ns2:stateOrCountry>TN</ns2:stateOrCountry>
                <ns2:zipCode>37203</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>(615) 724-7755</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>CAREY KOLAJA</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Director</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>E*TRADE FINANCIAL CORPORATION</name>
                <address>
                    <ns2:street1>3 EDISON DRIVE</ns2:street1>
                    <ns2:city>ALPHARETTA</ns2:city>
                    <ns2:stateOrCountry>GA</ns2:stateOrCountry>
                    <ns2:zipCode>30005</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>2500</noOfUnitsSold>
            <aggregateMarketValue>70600.00</aggregateMarketValue>
            <noOfUnitsOutstanding>84040352</noOfUnitsOutstanding>
            <approxSaleDate>06/15/2023</approxSaleDate>
            <securitiesExchangeName>NASD</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <acquiredDate>06/15/2023</acquiredDate>
            <natureOfAcquisitionTransaction>Stock Option Exercise</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>2500</amountOfSecuritiesAcquired>
            <paymentDate>06/15/2023</paymentDate>
            <natureOfPayment>Cash</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <noticeSignature>
            <noticeDate>06/15/2023</noticeDate>
            <planAdoptionDates>
                <planAdoptionDate>03/16/2023</planAdoptionDate>
            </planAdoptionDates>
            <signature>/s/ Carey O'Connor Kolaja</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3238}]
144
0001848717
XXXXXXXX
LIVE
0001479290
REVANCE THERAPEUTICS, INC.
001-36297
1222 Demonbreun Street, Suite 2000
Nashville
TN
37203
(615) 724-7755
CAREY KOLAJA
Director
Common
E*TRADE FINANCIAL CORPORATION
3 EDISON DRIVE
ALPHARETTA
GA
30005
2500
70600.00
84040352
06/15/2023
NASD
Common
06/15/2023
Stock Option Exercise
Issuer
N
2500
06/15/2023
Cash
Y
06/15/2023
03/16/2023
/s/ Carey O'Connor Kolaja